Oaktree Acquisition Corp III Life Sciences
OACC
49 hedge funds and large institutions have $179M invested in Oaktree Acquisition Corp III Life Sciences in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 0 closing their positions.
2% more funds holding
Funds holding: 48 → 49 (+1)
2% more capital invested
Capital invested by funds: $175M → $179M (+$3.56M)
0.88% more ownership
Funds ownership: 84.32% → 85.19% (+0.88%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$1.6M |
| 2 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$1.59M |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.57M |
| 4 |
DAM
Decagon Asset Management
London,
United Kingdom
|
+$331K |
| 5 |
SC
Sculptor Capital
New York
|
+$323K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$2.74M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$811K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$609K |
| 4 |
MSU
Mizuho Securities USA
New York
|
-$476K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$453K |
OACC Hedge Fund Activity: Q4 2025 in Review
49 of the 8,275 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences (OACC) for Q4 2025, worth a combined $179M — up 2% from $175M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new OACC positions and 0 closed out — a net gain of 1 holder — while 10 added to existing stakes and 12 trimmed.
The largest buyer was Radcliffe Capital Management, adding an estimated $1.6M. The largest seller was Toronto Dominion Bank, cutting an estimated $2.74M.
- 49 institutional investors held Oaktree Acquisition Corp III Life Sciences (OACC) as of Q4 2025, up from 48 in Q3 2025.
- Funds reported $179M of Oaktree Acquisition Corp III Life Sciences stock for Q4 2025, up 2% quarter-over-quarter.
- 1 fund opened new Oaktree Acquisition Corp III Life Sciences positions in Q4 2025 and 0 closed out, a net change of +1 holder.
- The largest Oaktree Acquisition Corp III Life Sciences buyer in Q4 2025 was Radcliffe Capital Management, an estimated $1.6M added.
- The largest Oaktree Acquisition Corp III Life Sciences seller in Q4 2025 was Toronto Dominion Bank, an estimated $2.74M sold.
Based on aggregated 13F filings for Q4 2025.